Abbreviations
Primary tumour
abemaciclib
abiraterone
alectinib
alpelisib
apalutamide
atezolizumab
avelumab
bevacizumab
brigatinib
cabazitaxel
cabozantinib
cemiplimab
cetuximab
cevanou
dabrafenib
darolutamide
enfortumab vedotin
enzalutamide
ipilimumab
lenvatinib
lorlatinib
niraparib
nivolumab
osimertinib
palbociclib
panitumumab
pembrolizumab
ribociclib
sacituzumab
selpercatinib
talazoparib
trametinib
trastuzumab
trastuzumab deruxtecan
tucatinib
